LSB MedTech Holding Group Ltd; A Leader in Medical Innovation
LSB MedTech Holding Group Ltd, originally founded in the Netherlands, has since relocated its headquarters to the United Arab Emirates while maintaining multiple subsidiaries across Europe. As a dynamic spin-off company, LSB MedTech excels in the invention, development, and production of advanced medical technologies. With a strong focus on innovation consultancy, artificial intelligence (AI)-driven solutions, and intellectual property (IP) valorization, the company has established itself as a key player in the medical technology sector.

Over the years, LSB MedTech has successfully developed, patented, manufactured, and licensed a wide range of next-generation medical devices and technologies, demonstrating its commitment to advancing healthcare and improving patient outcomes. This progress is driven by the integration of AI-powered technologies, including Clinical Decision Support Systems (CDSS), Large Language Models (LLMs), Natural Language Processing (NLP), and predictive AI models, which enhance diagnostic precision, optimize treatment pathways, and enable real-time patient monitoring.

Strategic Development
In mid-2023, LSB MedTech divested its CRO laboratory services to focus entirely on medical innovation, consulting, and valorization. Since then, these activities have continued under the name LSB MedTech, with operations managed from our headquarters in the UAE and partially from the Netherlands.